MTC associated with MEN 3 syndrome has
**Core Concept**
Medullary thyroid carcinoma (MTC) is a type of neuroendocrine tumor originating from the parafollicular cells (C cells) of the thyroid gland. Multiple Endocrine Neoplasia Type 3 (MEN 3) syndrome, also known as Multiple Endocrine Neoplasia Type 2B (MEN 2B), is a rare genetic disorder characterized by the development of MTC, pheochromocytoma, and other endocrine tumors.
**Why the Correct Answer is Right**
MEN 3 syndrome is caused by mutations in the RET proto-oncogene, which encodes a receptor tyrosine kinase involved in the signaling pathway of the glial cell line-derived neurotrophic factor (GDNF). The mutations lead to the constitutive activation of the RET protein, resulting in the uncontrolled growth and proliferation of C cells in the thyroid gland, ultimately causing MTC. The development of MTC in MEN 3 syndrome is a classic clinical feature, often presenting as a large, rapidly growing tumor in the thyroid gland.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because MEN 2A syndrome, not MEN 3, is associated with MTC, pheochromocytoma, and hyperparathyroidism.
* **Option B:** This option is incorrect because MEN 1 syndrome is characterized by the development of tumors in the parathyroid glands, pituitary gland, and pancreas, but not typically MTC.
* **Option C:** This option is incorrect because familial medullary thyroid carcinoma (FMTC) is a distinct clinical entity that presents with MTC, but is not associated with other endocrine tumors or the genetic mutations seen in MEN 3 syndrome.
**Clinical Pearl / High-Yield Fact**
MEN 3 syndrome is a rare but aggressive form of MTC, often presenting with a large, rapidly growing tumor in the thyroid gland. Early diagnosis and treatment are critical to prevent the development of metastatic disease and improve patient outcomes.
**Correct Answer:** D.